Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer

• Κύριοι συγγραφείς: Fangyan Gao (Συγγραφέας), Yueyao Wu (Συγγραφέας), Runtian Wang (Συγγραφέας), Yuhui Yao (Συγγραφέας), Yiqiu Liu (Συγγραφέας), Lingling Fan (Συγγραφέας), Jingtong Xu (Συγγραφέας), Jian Zhang (Συγγραφέας), Xin Han (Συγγραφέας), Xiaoxiang Guan (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2024-06-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Targeting androgen receptor (AR) has shown great therapeutic potential in triple-negative breast cancer (TNBC), yet its efficacy remains unsatisfactory. Here, we aimed to identify promising targeted agents that synergize with enzalutamide, a second-generation AR inhibitor, in TNBC. By using a strate...